The past decade has brought about major advances in the realms of both
healthcare and biometrics. New technologies and techniques in the field of biometrics
has allowed for the quick and efficient identification of people, while new...
The phase II clinical trial is a critical step in the drug development process. In the oncology setting, phase II studies typically evaluate one primary endpoint, which is efficacy. In practice, a binary measurement representing the response to the...
